Arcturus Therapeutics Ltd. — key financial figures for fiscal year 2018 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2018)

$15.8M

Net Income/Loss (FY2018)

-$21.8M

Total Assets (FY2018)

$44.2M

Total Equity (FY2018)

$13.6M

Cash Flows from Operating Activities (FY2018)

-$20.8M

Source: Arcturus Therapeutics Ltd. 10-K filing (FY2018). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.